Case Number:

PGR2022-00025

Case Type:

PGR

Status:

Trial Instituted

Petitioner:

Neurocrine Biosciences, Inc.

1. Filed: February 18, 2022 00:00

   Coverage

   1. December 05, 2023

      PTAB To Eye Hormone Drug Again In Patent Fight

      The Patent Trial and Appeal Board has agreed to look into whether various claims in a pair of patents owned by a biotechnology maker are invalid, the latest event in a larger intellectual property fight over a treatment for a hormonal disorder.

   ---

   Stay ahead of the curve

   In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

   
   

   • Search PTAB cases and full-text documents.
   • Download filings with the U.S. Patent & Trademark Office’s Patent Trial & Appeal Board.
   • Set up alerts on new cases, follow ongoing cases, track new decisions and so much more!

   TRY LAW360 FREE FOR SEVEN DAYS

   View the PTAB case documents

   Already a subscriber? Click here to login